GLP-1

WHAT IS SEMAGLUTIDE?

Is a glucagon-like peptide-1 (GLP-1)

Receptor agonist that is in a class of medication called incretin mimetics.

An active ingredient for weight loss and diabetic medications and is typically received through subcutaneous (subcu, sub-q) weekly injections. Semaglutide lowers blood glucose levels by assisting the pancreas, blocking a hormone called glucagon-like peptide-1 (which controls the flow of glucose into cells) and increasing the amount of insulin that is released. These in turn, lowers the amount of glucagon that is released and delays gastric emptying. Insulin helps move sugar from the blood into the other tissues where it is used for energy. As a result, Semaglutide;

1)  Slow down the movement of food through the stomach, after eating, the client feels full longer.

2)  Suppresses appetite and food cravings.